Mostly Markets
Subscribe
Stocks/Health Care/Health Care Distributors

CencoraCOR

Health Care Distributors · Conshohocken, Pennsylvania · In the S&P 500
$330.84+0.09%After hours: $326.52 (−1.31%)At the close, 30 Oct · Prices from CNBC, may be delayed
▼ 0.7% over 1 year
Cencora over 1 yearDaily close, $, to 30 Oct 2026
$250$300$350Nov2026MarMayJulSep$330.84$250$300$350NovMarJul$330.84
Source: Nasdaq daily closes
Market value$63.13B
Price to earnings24.6x
Forward P/E17.1x
Dividend yield0.73%
Year to date−2.0%
One year−0.7%
Next earningsWed 4 Nov, before the open
SectorHealth Care
52-week range (closes)
$252.74$374.75

Quality and valuation

How Cencora compares with other health care stocks. A description, not a recommendation.

Cencora and 5 health care distributors peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: weaker than mostValuation: in line with its sector

A weaker business than most health care companies, priced about in line with them.

Cencora trades at 17.1 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +5.1% vs +7.8%
  • Keeps less of each sale (gross margin): 4.0% vs 65.3%
  • Less profitable (operating margin): 0.9% vs 13.3%
  • Turns less of its sales into cash: 1.2% vs 15.9%
COR trades at 17.1x forward earnings, below the sector medianForward p/e, Health Care Distributors peers
NVS17.0xCOR17.1xAZN17.5xMRK18.1xUNH18.9xABBV19.6xJNJ25.1xLLY36.3xSector median 19.1xNVS17.0xCOR17.1xAZN17.5xMRK18.1xUNH18.9xABBV19.6xJNJ25.1xLLY36.3xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 24.6x earnings, COR is cheaper than its average since Jul 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
20x30x40xAverage 31.9x2025202624.6x20x30x40xAverage 31.9x2025202624.6x
Source: Nasdaq prices; SEC filings

Financials

From Cencora's SEC filings, through the quarter ending 30 Jun 2026. Hover or tap a bar for its value.

Revenue grew 5.1% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0bn$25bn$50bn$75bnQ4 ’24Q2 ’25Q4 ’25$84.8bnQ3 ’26$0bn$50bnQ4 ’24Q2 ’25Q4 ’25$84.8bnQ3 ’26
Source: SEC filings
Growth sped up to +5.1% last quarterRevenue growth, year on year, %
0%5%10%Q4 ’24Q2 ’25Q4 ’255.1%Q3 ’260%5%10%Q4 ’24Q2 ’25Q4 ’255.1%Q3 ’26
Source: SEC filings
Operating margin was 1.3% last quarterOperating income as a share of revenue, %
0.0%0.5%1.0%1.5%Q4 ’24Q2 ’25Q4 ’251.3%Q3 ’260.0%0.5%1.0%1.5%Q4 ’24Q2 ’25Q4 ’251.3%Q3 ’26
Source: SEC filings
Free cash flow was $4.1 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $bn
$-2bn$0bn$2bnQ4 ’24Q2 ’25Q4 ’25$2.4bnQ3 ’26$-2bn$0bn$2bnQ4 ’24Q2 ’25Q4 ’25$2.4bnQ3 ’26
Source: SEC filings
Last 12 monthsCORSector median
Revenue growth+5.1%+7.8%
Gross margin4.0%65.3%
Operating margin0.9%13.3%
Free cash flow margin1.2%15.9%
Price to earnings24.6x30.2x

Stories on Cencora

We haven't written about Cencora yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Distributors, by market value.

CompanyPriceTodayYTDValue
LLYEli Lilly$1,417.54+3.19%+31.9%$1.33T
JNJJohnson & Johnson$273.20−0.73%+32.0%$658B
ABBVAbbVie$294.89+1.41%+29.1%$521B
MRKMerck$149.52+2.18%+42.0%$369B
UNHUnitedHealth$406.97−0.96%+23.3%$365B
NVSNovartis$160.79−0.19%+16.6%$327B
AZNAstraZeneca$186.65+7.02%+6.4%$290B
TMOThermo Fisher Scientific$697.00−1.72%+20.3%$258B